Risk assessment of endogenous formation of carcinogenic N-nitroso compounds in response to intake of NO-aspirin.
Kleinjans
Jos
J
de Kok
Theo
T
Engels
Leopold
L
D000893:Anti-Inflammatory Agents / Q000378:metabolism / Q000493:pharmacokinetics*; D001241:Aspirin / Q000031:analogs & derivatives / Q000378:metabolism / Q000493:pharmacokinetics*; D002273:Carcinogens / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics; D006801:Humans; D009603:Nitroso Compounds / Q000097:blood / Q000378:metabolism*; D018570:Risk Assessment
D000893:Anti-Inflammatory Agents; D002273:Carcinogens; D009603:Nitroso Compounds; C102148:nitroaspirin; D001241:Aspirin